Ocular Therapeutix: Chief legal officer Anderman Todd sold 11,984 shares

What happened

• The filing reports that Anderman Todd, chief legal officer, sold 11,984 shares of Ocular Therapeutix common stock on Oct 8, 2026, in an open market or private sale (code S) for total proceeds of $87,363 at a weighted average price of $7.29.

Key details

• Transaction date and price: Oct 8, 2026; weighted average price $7.29; individual sale prices ranged from $7.10 to $7.45 (multiple transactions).
• Shares owned after the transaction: the filing does not report shares owned after the transaction.
• Relevant footnotes: F1 states the sales were made pursuant to a durable automatic sale instruction adopted Oct 7, 2024, to effect a sell-to-cover election to satisfy tax withholding for restricted stock units that vested Oct 7, 2026, and that the sales were not discretionary. F2 states the reported price is a weighted average and that the reporting person can provide a breakdown of the number of shares sold at each price on request.
• Filing timeliness: Form filed on Oct 13, 2026, five days after the reported transaction (filed late).

Why it may matter

• The filing indicates this was a sell-to-cover transaction to satisfy tax withholding related to RSU vesting and was executed under an automatic instruction rather than as a discretionary sale.
• A filing does not show why the insider traded or why the company acted.